其他
EMA 将采取措施避免药品审评过程中的偏见
[1] European Medicines Agency's actions to address the European Ombudsman's decision on EMA's pre-submission activities
[2] Vibha Sharma. EMA Heeds Ombudsman's Advice On Avoiding Perception Of Bias In Drug Evaluations.
[3] Ed Silverman. EMA adopts EU Ombudsman recommendations to avoid bias concerns over drug approvals.
[4] 识林资讯：申报前会议可能给 EMA 审批过程带来偏见？
长按下方二维码下载识林®App
识林®版权所有，未经许可不得转载。